We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

84 hedge funds and large institutions have $41.2M invested in Accelerate Diagnostics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 8

121% more capital invested

Capital invested by funds: $18.6M → $41.2M (+$22.6M)

14% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 14

14% more funds holding

Funds holding: 74 → 84 (+10)

85% less call options, than puts

Call options by funds: $190K | Put options by funds: $1.23M

Holders
84
Holders Change
+10
Holders Change %
+13.51%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
19
Increased
16
Reduced
14
Closed
8
Calls
$190K
Puts
$1.23M
Net Calls
-$1.04M
Net Calls Change
-$228K

Top Buyers

Rank Fund Capital Flow
1
GAM
Griffin Asset Management
New York
+$5.5M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$2.88M
3
JP Morgan Chase
JP Morgan Chase
New York
+$1.77M
4
Millennium Management
Millennium Management
New York
+$1.19M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$862K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.88M
2
OIM
Oracle Investment Management
Connecticut
-$392K
3
CIA
Cladis Investment Advisory
Montana
-$137K
4
E
Ergoteles
New York
-$131K
5
HF
HRT Financial
New York
-$114K
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$207K +$226K +13,658 New
GCP
27
GSA Capital Partners
United Kingdom
$183K +$200K +12,070 New
TIM
28
Thompson Investment Management
Wisconsin
$173K – – –
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
$163K +$177K +10,698 New
Two Sigma Advisers
30
Two Sigma Advisers
New York
$139K +$7.28K +440 +5%
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$138K – – –
Northern Trust
32
Northern Trust
Illinois
$126K +$430 +26 +0.3%
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$108K +$117K +7,093 New
TWA
34
TCI Wealth Advisors
Arizona
$84K – – –
Citadel Advisors
35
Citadel Advisors
Florida
$78K -$1.88M -113,627 -96%
Jane Street
36
Jane Street
New York
$73K -$86.1K -5,202 -52%
Group One Trading
37
Group One Trading
Illinois
$58K +$63.2K +3,816 New
Morgan Stanley
38
Morgan Stanley
New York
$57K -$77.6K -4,691 -56%
CL
39
CSS LLC
Illinois
$55K – – –
HighTower Advisors
40
HighTower Advisors
Illinois
$54K – – –
Charles Schwab
41
Charles Schwab
California
$47K +$50.5K +3,051 New
XT
42
XTX Topco
Cayman Islands
$47K +$51.6K +3,118 New
Baird Financial Group
43
Baird Financial Group
Wisconsin
$46K – – –
CIBC Private Wealth Group
44
CIBC Private Wealth Group
Georgia
$45K -$166 -10 -0.3%
Goldman Sachs
45
Goldman Sachs
New York
$44K -$27.8K -1,678 -37%
SWM
46
SeaCrest Wealth Management
New York
$41K – – –
MW
47
Marcum Wealth
Ohio
$33K – – –
Bank of America
48
Bank of America
North Carolina
$31K -$5.3K -320 -14%
CC
49
Chicago Capital
Illinois
$30K – – –
CSS
50
Cubist Systematic Strategies
Connecticut
$29K +$31.1K +1,877 New
1
2
3 4

AXDX Hedge Fund Activity: Q3 2022 in Review

84 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2022, worth a combined $41.2M — up 121% from $18.6M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new AXDX positions and 8 closed out — a net gain of 11 holders — while 16 added to existing stakes and 14 trimmed.

The largest buyer was Griffin Asset Management, adding an estimated $5.5M. The largest seller was Citadel Advisors, cutting an estimated $1.88M.

  • 84 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2022, up from 74 in Q2 2022.
  • Funds reported $41.2M of Accelerate Diagnostics stock for Q3 2022, up 121% quarter-over-quarter.
  • 19 funds opened new Accelerate Diagnostics positions in Q3 2022 and 8 closed out, a net change of +11 holders.
  • The largest Accelerate Diagnostics buyer in Q3 2022 was Griffin Asset Management, an estimated $5.5M added.
  • The largest Accelerate Diagnostics seller in Q3 2022 was Citadel Advisors, an estimated $1.88M sold.

Based on aggregated 13F filings for Q3 2022.